Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Total 13F shares
-
2,390,244
-
Share change
-
-686,011
-
Total reported value
-
$35,543,000
-
Price per share
-
$14.87
-
Number of holders
-
16
-
Value change
-
-$7,828,421
-
Number of buys
-
9
-
Number of sells
-
3
Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q2 2018
As of 30 Jun 2018,
Krystal Biotech, Inc. - COMMON STOCK (KRYS) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,390,244 shares.
The largest 10 holders included
FMR LLC, Knoll Capital Management, LP, Tourbillon Capital Partners, L.P., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Artal Group S.A., HIGHBRIDGE CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, and JPMORGAN CHASE & CO.
This page lists
16
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.